Yvonne Chen

Aug 22, 2024 | cell.com | Yvonne Chen |Charles Evavold |Matthias Mann |Emily Davenport

In vitro human cell-based models: What can they do and what are their limitations?

Jul 25, 2024 | insights.bio | Yvonne Chen

This is a live-only webinar with no on demand access available. The adoptive transfer of T cells expressing chimeric antigen receptors (CARs) has demonstrated robust efficacy in the treatment of advanced hematological malignancies. However, challenges such as antigen escape and immunosuppression limit the long-term efficacy of adoptive T cell therapy, particularly for solid tumors.